Skip to main content

Table 5 Distribution of AS on WBMRI compared with other imaging modalities

From: Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?

AS on WBMRI

Compared to FDG-PET/CT

Compared to CT or CT & BS

Bone only

3

13

Liver only

1

16

Bone and liver

0

4

Peritoneal/retroperitoneal

0

3

Liver and peritoneal

0

2

Nodes

1

1